Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|33|2|335-338

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.33, Iss.2, 2018-02, pp. : 335-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1834-1839

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 981-986

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 1, 2018-01 ,pp. : 72-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progressive Supranuclear Palsy Manifesting With Depressive Features

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 34, Iss. 9, 1986-09 ,pp. : 663-665

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten Years and Counting: Moving Leucine‐Rich RepeatKinase 2 Inhibitors to the Clinic

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 2, 2015-02 ,pp. : 180-189

John Wiley & Sons Inc

Access to resources Recommend Favorite